The U.S. Food and Drug Administration approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.
Federal health officials said a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs that have been used for 20 years.
Pozen Inc. said that it filed a patent infringement lawsuit against generic drugmaker Dr. Reddy's Laboratories Ltd., which is seeking approval for a generic version of its osteoarthritis drug Vimovo.
Researchers have discovered a compound called L-BHDA that has the potential to be more effective than existing agents in treating the very painful blisters known as shingles.
Researchers have published promising results of a clinical study using pirfenidone, an experimental anti-fibrotic and anti-inflammatory drug, to treat patients with diabetic nephropathy.
UCLA researchers have demonstrated the ability to package drug-loaded "nanodisks" into naturally occurring nanoscale capsules that have been engineered for therapeutic drug delivery.
Scientists are developing a technique based on a new discovery which could pave the way towards detecting Alzheimer's disease in its earliest stages.
Scientists have developed the first of a new class of highly selective compounds that effectively suppresses the severity of multiple sclerosis in animal models.
Researchers have identified several genes that may be implicated in the malaria parasite's notorious ability to rapidly evade drug treatments.
Researchers have for the first time observed the activity of a single gene in living cells, following the process of gene transcription.
Pfizer Inc. confirmed that one patient who was taking its drug candidate tofacitinib, a pill designed to treat rheumatoid arthritis, died during a recent clinical trial and said the death was connected to the drug.
Eisai Co. has received approval to market its novel anticancer Halaven Injection 1mg (eribulin mesylate) in Japan for the treatment of inoperable and recurrent breast cancer.
Daiichi Sankyo has received its first marketing approval for LIXIANA 15 mg and 30 mg tablets by the Ministry of Health, Labor and Welfare in Japan.
TTP LabTech introduced the Acumen eX3 high content, microplate imaging system, which features a 561nm laser.